Načítá se...
Management of atrial fibrillation: focus on the role of dronedarone
BACKGROUND: Dronedarone is an amiodarone derivative that was approved in the US in July 2009 to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF), who are in sinus rhythm (SR), or who will be cardioverted. OBJECTIVE: This article rev...
Uloženo v:
| Vydáno v: | Open Access Emerg Med |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4753968/ https://ncbi.nlm.nih.gov/pubmed/27147853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OAEM.S16679 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|